TACR1 and depressive disorder: While ex vivo experiments, non-human primate and human clinical studies indicate that NK1R antagonists may have limited use as monotherapy in HIV, they may be beneficial when used in combination with anti-retrovirals in chronic HIV given their anti-inflammatory effects and potential to improve neurocognitive functions through possible reduction in symptoms of depression and anxiety as well as improved sleep [40].